Amgen meldet für das Gesamtjahr 2025 einen GAAP-Gewinn je Aktie von 14,23 USD, ein Anstieg um 88 Prozent
I'm PortAI, I can summarize articles.
Amgen Inc. reported a GAAP earnings per share of $14.23 for 2025, an 88% increase. Q4 revenues rose 9% to $9.90 billion, driven by a 7% increase in product sales. Total revenues for 2025 reached $36.80 billion, up 10%. The company expects 2026 revenues between $37.00 billion and $38.40 billion, with EPS estimated at $15.45 to $16.94 (GAAP). Planned investments are around $2.60 billion, with share buybacks up to $3 billion. Amgen continues to focus on innovative therapies and sustainable growth.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments